These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 34134698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B, van Roode T, Pagan F, Phillips P, Wagner H, Calder S, Aasen J, Pauly B, Hore D.
    Harm Reduct J; 2020 May 12; 17(1):29. PubMed ID: 32398090
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T, Hayashi K, Nosova E, Milloy MJ, DeBeck K, Wood E, Kerr T, Ti L.
    Am J Drug Alcohol Abuse; 2020 Jul 03; 46(4):506-511. PubMed ID: 31983241
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Substance Use Stigma and Community Drug Checking: A Qualitative Study Examining Barriers and Possible Responses.
    Davis S, Wallace B, Van Roode T, Hore D.
    Int J Environ Res Public Health; 2022 Nov 30; 19(23):. PubMed ID: 36498052
    [Abstract] [Full Text] [Related]

  • 7. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK, Tupper KW, Fairbairn N.
    Int J Drug Policy; 2018 Dec 30; 62():59-66. PubMed ID: 30359874
    [Abstract] [Full Text] [Related]

  • 8. Third party drug checking: accessing harm reduction services on the behalf of others.
    Larnder A, Burek P, Wallace B, Hore DK.
    Harm Reduct J; 2021 Sep 17; 18(1):99. PubMed ID: 34535157
    [Abstract] [Full Text] [Related]

  • 9. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK, Borne E, Esteves Camacho T, Kelly M, Rising KL.
    Harm Reduct J; 2024 Jan 30; 21(1):26. PubMed ID: 38287409
    [Abstract] [Full Text] [Related]

  • 10. Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking.
    Wallace B, van Roode T, Burek P, Hore D, Pauly B.
    Harm Reduct J; 2022 Dec 20; 19(1):143. PubMed ID: 36539747
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. "I couldn't live with killing one of my friends or anybody": A rapid ethnographic study of drug sellers' use of drug checking.
    Betsos A, Valleriani J, Boyd J, Bardwell G, Kerr T, McNeil R.
    Int J Drug Policy; 2021 Jan 20; 87():102845. PubMed ID: 33246303
    [Abstract] [Full Text] [Related]

  • 13. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
    Vandergrift GW, Gill CG.
    J Mass Spectrom; 2019 Sep 20; 54(9):729-737. PubMed ID: 31432563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.
    Goodyear T, Mniszak C, Jenkins E, Fast D, Knight R.
    Harm Reduct J; 2020 Mar 30; 17(1):23. PubMed ID: 32228646
    [Abstract] [Full Text] [Related]

  • 16. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A, Xavier J, Corser J, Fleury M, Lock K, Mehta A, Lamb J, McDougall J, Newman C, Buxton JA.
    BMC Public Health; 2023 Apr 03; 23(1):640. PubMed ID: 37013524
    [Abstract] [Full Text] [Related]

  • 17. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N, McDonald K, Stefan C, Beriault DR, Mason K, Barnaby L, Altenberg J, MacDonald RD, Caldwell J, Nisenbaum R, Leece P, Watson TM, Tupper KW, Kufner L, Scheim AI, Werb D, Drug Checking Services in Toronto Working Group.
    Harm Reduct J; 2020 Jan 28; 17(1):9. PubMed ID: 32204713
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA, Saatchi A, Vandergrift GW, Palaty J, Lysyshyn M, Gill CG.
    Drug Alcohol Rev; 2022 Feb 28; 41(2):410-418. PubMed ID: 34347332
    [Abstract] [Full Text] [Related]

  • 20. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
    People with Lived Expertise of Drug Use National Working Group, Austin T, Boyd J.
    Harm Reduct J; 2021 Jan 06; 18(1):1. PubMed ID: 33407500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.